Slide Kit Service

The following clinical studies are available as powerpoint presentations:

• Memantine in Moderate-to-Severe Alzheimer’s Disease
  Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ (2003). New England Journal of Medicine, 348 (14): 1333-41.

• Memantine in Severe Dementia: Results of the M-BEST Study
  Winblad B & Poritis N (1999). International Journal of Geriatric Psychiatry, 14 (2): 135-46.

• Resource Ultilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease
  Wimo A, Winblad B, Stöffler A, Wirth Y, Möbius HJ (2003). Pharmacoeconomics, 21 (5): 327-40.

• Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia (MMM 300)
  Orgogozo JM, Rigaud AS, Stöffler A, Möbius HJ, Forette F (2002). Stroke, 33 (7): 1834-9.

• A Double-blind, Placebo-controlled Multicentre Study of Memantine in Mild to Moderate Vascular Dementia (MMM 500)
  Wilcock G, Möbius HJ, Stöffler A (2002). Int Clin Psychopharmacol, 17 (6): 297-305.